Lilly also said it would not increase its drug prices through the end of the year, following similar moves by Pfizer Inc, Merck & Co Inc and Novartis AG, as the Trump Administration pushes to cut costs for patients. Shares of the company rose as much as 2.6 percent to a near three-year high of $91.20.
from Yahoo News - Latest News & Headlines https://ift.tt/2uKaIke
0 coment�rios: